In order to further improve the public health assurance system and the infectious diseases early warning system to give play to their positive roles and enhance their collaborative capacity, this paper, based on the big and thick data analytics technology, designs a 'rolling-type' data synergy model. This model covers districts and counties, municipalities, provinces, and the country. It forms a data blockchain for the public health assurance system and enables high sharing of data from existing system platforms such as the infectious diseases early warning system, the hospital medical record management system, the public health data management system, and the health big and thick data management system. Additionally, it realises prevention, control and early warning by utilising data mining and synergy technologies, and ideally solves problems of traditional public health assurance system platforms such as excessive pressure on the 'central node', poor data tamper-proofing capacity, low transmission efficiency of big and thick data, bad timeliness of emergency response, and so on. The realisation of this technology can greatly improve the application and analytics of big and thick data and further enhance the public health assurance capacity.

San Francisco — The Washington State Nurses Association is among four labor unions suing Secretary of Labor Eugene Scalia and OSHA in an effort to compel the agency to move forward with rulemaking on an infectious diseases standard that would require employers in the health care industry to protect workers from exposure to harmful infectious diseases such as COVID-19, Ebola and influenza.

Columbia, SC — South Carolina OSHA has announced its plan to adopt a standard on infectious diseases in the workplace, including COVID-19.

Research Triangle Park, NC – Outbreaks of viruses such as Ebola and Zika have prompted the National Institute of Environmental Health Sciences – together with the Centers for Disease Control and Prevention, OSHA, and the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response – to launch an infectious disease safety training program for first responders and hazardous waste workers.

Washington — A new Government Accountability Office report recommends OSHA look at “available actions” – including developing a standard on infectious disease – to help protect workers in the meat and poultry processing industries.

Washington — OSHA’s proposed rule on infectious diseases in “health care and other high-risk environments” has been submitted to the White House Office of Information and Regulatory Affairs for final review.

The opioid epidemic in the U.S. is driving a simultaneous epidemic of infectious diseases — including HIV, hepatitis C virus (HCV) and bacterial infections, and sexually transmitted infections — but workforce shortages, stigma, and financial and policy barriers are preventing the integration of opioid use disorder (OUD) and infectious disease services, says a new report from the National Academies of Sciences, Engineering, and Medicine.

WASHINGTON — In response to the COVID-19 outbreak, the White House Office of Science and Technology Policy has asked the National Academies of Sciences, Engineering, and Medicine to establish a Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats.

Formed earlier this month, the National Academies’ Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats was assembled at the request of the White House Office of Science and Technology Policy and the Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak.

The recently formed National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, assembled at the request of the White House Office of Science and Technology Policy and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak, has been providing rapid expert consultations on several topics, such as social distancing and severe illness in young adults.

The recently formed National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, assembled at the request of the White House Office of Science and Technology Policy (OSTP) and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak, has been providing rapid expert consultations on several topics, such as social distancing and severe illness in young adults.

A new rapid expert consultation from a standing committee of the National Academies of Sciences, Engineering, and Medicine responds to questions from the White House Office of Science and Technology Policy (OSTP) regarding survival of the COVID-19 virus in relation to temperature and humidity and potential for seasonal reduction and resurgence of cases.

A new rapid expert consultation from a standing committee of the National Academies of Sciences, Engineering, and Medicine.

A new rapid expert consultation from a standing committee of the National Academies of Sciences, Engineering, and Medicine responds to questions from the White House Office of Science and Technology Policy (OSTP) regarding the effectiveness of homemade fabric masks to protect others from the viral spread of COVID-19 from potentially contagious asymptomatic or presymptomatic individuals.

The CDC’s Division of Global Migration and Quarantine should create an effective and innovative quarantine station model to confront new challenges in preventing the spread of infectious diseases in the U.S., and requires new investment and regulatory reforms to do so.

Among the many parts of the U.S. public health system strained by the COVID-19 pandemic were the Centers for Disease Control and Prevention’s Division of Global Migration and Quarantine and its network of quarantine stations. A recent report explored how to improve these stations based on lessons learned during the pandemic.

Throughout the COVID-19 pandemic, wastewater surveillance has provided advance indications of community-level outbreaks, sometimes weeks before other indicators. A new report says that wastewater surveillance is worthy of investment and outlines a vision for the future of a national system.

Institut Pasteur Korea (IPK) and the Institut Pasteur (Paris) signed an agreement for the creation of a Pasteur Joint International Research Unit (PIU) titled: "Artificial intelligence for image-based drug discovery & development" (Ai3D).

Jose Giron is a dedicated educator and tireless patient advocate

Ghalib Mannan channels years of expertise into his work with Mid-South Infectious Disease Associates

Mami Taniuchi serves as an associate professor of medicine at the University of Virginia.

Targeting two global pig diseases, and improving health and immune support in newly weaned piglets

Proteomics analysis reveals the differential protein expression of female and male adult Toxocara canis using Orbitrap Astral analyzer  Infectious Diseases of Poverty - BioMed Central

The pandemic has marked a turning point for an underutilized technology for infectious disease control in buildings.

By Fran Kritz, NPR

The ancient scourge of tuberculosis for years was the deadliest infectious disease. Then SARS-CoV-2 came along and grabbed the notorious title of #1 killer: In 2020, COVID-19 was responsible for 3.5 million deaths worldwide vs 1.5 million for TB.The 2024 Global Tuberculosis Report, published last week by the World Health Organization, puts TB back in the top slot with 1.25 million deaths in 2023 compared to 320,000 COVID-19 deaths. There's also been an increase of hundreds of thousands of new TB cases in 2023 compared to the year prior.

The 1.25 million TB deaths in 2023 is down from 2022’s number of 1.32 million (which that year was second to the COVID toll). But it's still indefensibly high, say public health leaders.

“The fact that TB still kills and sickens so many people is an outrage, when we have the tools to prevent it, detect it and treat it,” said Tedros Adhanom Ghebreyesus, WHO director-general, in a statement issued on October 29.

According to the report, approximately 8.2 million people were newly diagnosed with TB in 2023 — the highest number since WHO began global TB monitoring in 1995 and a “notable increase” from 7.5 million people newly diagnosed in 2022.

TB sleuths are trying to figure out the reasons behind the increase. Anand Date, global TB branch chief at the Centers for Disease Control and Prevention, says population growth may account for the increase in cases last year -- and that it may take until the 2024 to find out if that is so or if the leap in 2023 reflects an undercount of annual TB totals during the pandemic.

“Disruptions to TB programs during the height of the pandemic led to more people going undiagnosed and untreated for TB. [And] guidance to shelter in place may have also limited the spread of TB, says Yogan Pillay, who heads efforts to improve TB program delivery at the Bill and Melinda Gates Foundation (which is a funder of NPR and this blog).

COVID-19 did trigger a new setback in the effort to control TB. But most of the reasons the infection persists are frustratingly well-known, says Lucica Ditiu, executive director of the Stop TB Partnership. There's too little money for research, treatment. and patient care needs. And there's stigma that can keep the most common victims of TB, impoverished people including migrants and sex workers, from seeking help or being offered treatment.

In addition, health conditions like malnutrition, diabetes and smoking that can exacerbate TB and keep medications from being fully effective, says Luke Davis, a TB and HIV specialist at the Yale School of Public Health. “TB is unusual,” says Davis, in that most people who are exposed to the bacteria won’t progress to infectious TB. Only about 10% do, and they are usually among the world’s poorest people often with poor health to begin with, which exacerbates their condition.”

So what's the solution?

And that brings us to the Tedros point. The world knows how to vanquish TB — but is not doing a good job.

Money reigns as perhaps the biggest obstacle to conquering tuberculosis. A spokesperson for WHO tells NPR: “Compared with global funding targets for TB set at the 2023 U.N. high-level meeting on TB, there are large funding shortfalls for TB research as well as prevention, detection and treatment services. To close these gaps, more funding is needed from both domestic sources in the countries most impacted by TB and from international donors.”

Global funding for TB prevention and care decreased in 2023 from $6 billion in the three previous years to $5.7 billion and remains far below the yearly target of $22 billion, according to WHO.

What would more money bring? WHO cites expanded rapid diagnostic testing as critical. Then treatment can start sooner. And people wouldn’t have to travel long distances to a clinic then wait for days for the results.

Increased funding would also help reimburse families for lost wages and food and travel expenses incurred as they go for treatment. Those costs keep some patients and their families from seeking care.

The WHO report and other investigations also say that countries burdened by TB also have to step up and spend more money on prevention, diagnosis and treatment. A report by MSF/Doctors Without Borders published last month, for example, found that, only 5 out of 14 countries have adapted their guidelines — based on WHO recommendations -- to initiate TB treatment in children when symptoms strongly indicate TB disease, even if bacteriological tests are negative.

And increased funding would speed up the pace of research says the CDC’s Date. Funding for TB research has stagnated at around $1 billion per year, constraining progress, according to WHO. The target at the U.N. meeting: $5 billion per year by 2027. “The world also has the most promising R&D pipeline of new TB tools in decades,” says Pillay. “What’s needed now is greater investment to deliver on the promise of that pipeline and ensure patients and those at risk of TB have affordable and equitable access to these tools when they are available.”

Vaccines in the works

Pillay says there are more than a dozen TB vaccine candidates in clinical trials, including one whose late stage (stage 3) clinical trial is sponsored by the Gates Medical Research Institute. The trial began recruiting patients last March. That vaccine candidate is called M72/AS01E and if proven effective would be the first new TB vaccine in 100 years. The lone TB vaccine available now is not predictably effective in adults, and can cause a false positive result on TB skin tests.

But even an effective vaccine won’t do that much good if there aren’t funds to purchase it for countries impacted by TB. Janeen Madan Keller, deputy director of the Global Health Policy Program at the Center for Global Development, based in Washington, D.C., says that while Gavi, The Vaccine Alliance, pays for [a variety of] vaccines in some of the poorest countries such as Afghanistan, Burundi and the Democratic Republic of the Congo, some countries with high rates of TB are middle income countries, like Indonesia, and no longer eligible for support. Ahead of a TB vaccine’s approval, says Keller, there needs to be a better match of policy and funding.

“Often it seems that when we find a way to help vanquish TB,” says Lucica Ditiu, “we also find another barrier.”

Fran Kritz is a health policy reporter based in Washington, D.C., and a regular contributor to NPR. She also reports for the Washington Post and Verywell Health. Find her on X: @fkritz

The American Ingenuity Award winner is on the brink of using the human genome to provide better diagnostics for deadly diseases

Help Kids Defeat the Mouth Monsters

With India battling swine flu, an eminent Indian-American doctor has said it is the right time the government in the country accelerate process of training its doctors in infectious diseases or else it could be too late to bring the situation under control.

The opioid epidemic in the U.S. is driving a simultaneous epidemic of infectious diseases — including HIV, hepatitis C virus (HCV) and bacterial infections, and sexually transmitted infections — but workforce shortages, stigma, and financial and policy barriers are preventing the integration of opioid use disorder (OUD) and infectious disease services, says a new report from the National Academies of Sciences, Engineering, and Medicine.

WASHINGTON — In response to the COVID-19 outbreak, the White House Office of Science and Technology Policy has asked the National Academies of Sciences, Engineering, and Medicine to establish a Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats.

Formed earlier this month, the National Academies’ Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats was assembled at the request of the White House Office of Science and Technology Policy and the Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak.

The recently formed National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, assembled at the request of the White House Office of Science and Technology Policy and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak, has been providing rapid expert consultations on several topics, such as social distancing and severe illness in young adults.

The recently formed National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, assembled at the request of the White House Office of Science and Technology Policy (OSTP) and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak, has been providing rapid expert consultations on several topics, such as social distancing and severe illness in young adults.

A new rapid expert consultation from a standing committee of the National Academies of Sciences, Engineering, and Medicine responds to questions from the White House Office of Science and Technology Policy (OSTP) regarding survival of the COVID-19 virus in relation to temperature and humidity and potential for seasonal reduction and resurgence of cases.

A new rapid expert consultation from a standing committee of the National Academies of Sciences, Engineering, and Medicine.

A new rapid expert consultation from a standing committee of the National Academies of Sciences, Engineering, and Medicine responds to questions from the White House Office of Science and Technology Policy (OSTP) regarding the effectiveness of homemade fabric masks to protect others from the viral spread of COVID-19 from potentially contagious asymptomatic or presymptomatic individuals.

Health experts have called for a proactive, joined-up approach to public health in Europe under a changing climate. A recent study has examined the evidence for the influence of the climate on infectious disease and proposes a new integrated network for environmental and health data.

Climate change may increase the risk of outbreaks of infectious diseases, such as salmonella or tick-borne encephalitis. A new study has outlined five main steps in assessing policies to ensure that they can respond effectively to this challenge and highlights the importance of involving stakeholders at every stage of policy assessment.

Infectious Disease Advisor editor Natasha Priya Dyal, M.D., joins The PR Week to discuss the one topic on everyone's mind: COVID-19.

Dr. Bhayani lends years of expertise to his work as a physician advisor with Texas Health Resources

With the capability to analyze huge amounts of data, including medical information, human behavior patterns, and environmental conditions, big data tools can be invaluable in dealing with deadly outbreaks.

A catastrophic loss in biodiversity, reckless destruction of wildland and warming temperatures have allowed disease to explode. Ignoring the connection between climate change and pandemics would be “dangerous delusion,” one scientist said. The scientists who study how diseases emerge in a changing environment knew this moment was coming.…

A pharmaceutical composition comprising lectins is anti-tumorigenic and anti-viral, bacterial or protozoan. The composition, termed BiOmune is also useful for imaging, diagnosis and therapy of cancer.

The risk of disease transmission at airports and on aircraft is similar to the risks associated with other densely populated places. There are also unique factors related to the interaction of individuals from geographically diverse regions with differing immunity and endemic diseases. The TRB Airport Cooperative Research Program's ACRP Report 91: Infectious Disease Mitigation in Airports and on Aircraft offers guidance for mitigating the risk of disease spread via droplet, airborne, and contact at airpo...

Mathematical modeling and AI can pick out patterns preceding epidemics that human brains can’t readily discern.

Collecting and analyzing real-time data on the number of cases and deaths during a disease outbreak is crucial. Here's why we've failed.

When we arrived in China to pick up our adopted daughter, we found out she had chickenpox. The days of waiting were the most anxious of our lives.

Do biodiversity losses aggravate transmission of infectious diseases spread by animals to humans? The jury is still out but several scientists say there is a "biodiversity dilution effect" in which declining biodiversity results in increased infectious-disease transmission.